Home › NDC Lookup › Ingredients › Meclizine Hcl › 70677-1290-01
Motion Sickness Meclizine HCl 25 mg Tablet, Chewable, 100-count — NDC 70677-1290-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Motion Sickness Meclizine HCl 25 mg Tablet, Chewable, 100-count — NDC 70677-1290-1 (Billing 70677-1290-01)

by Strategic Sourcing Services LLC · 100 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC

This is a package of 100 tablets of Motion Sickness Meclizine HCl 25 mg Tablet, Chewable from Strategic Sourcing Services LLC, marketed since May 2025 and currently FDA-listed; retail pharmacies pay about $0.0333 per tablet (NADAC). It is this product's only package size.

NDC 70677-1290-01
🏷️ FDA NDC (as labeled) 70677-1290-1 billing pads the package segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70677-1290-1
Product NDC 70677-1290
11-digit billing NDC 70677129001
NCPDP billing unit EA — each (per item)
RxCUI 995632
UNII HDP7W44CIO
UPC 0010939961495
Application # M009
SPL Set ID 550b803c-a038-455c-908a-a6244c0952ba
Established class (EPC) Antiemetic
Physiologic effect Emesis Suppression
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-05-30
Route ORAL
Dosage form TABLET, CHEWABLE
Substance MECLIZINE HYDROCHLORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 50200050000510
GCN Seq No 004736
GCN 18312
HICL code 001975
Ingredient (HICL) Meclizine Hcl
HIC1 code H
Therapeutic class — broad (HIC1) Nervous System (Except Autonomic)
HIC2 code H6
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Midbrain
HIC3 code H6J
Therapeutic class — specific (HIC3) Antiemetic/Antivertigo Agents
AHFS code 04:04.16.00
AHFS class Piperazine Derivatives
FDB label name FT MOTION SICKNESS 25 MG CHWTB
FDB brand name Motion Sickness
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 004736
  • GCN: 18312
  • GPI-14 (Medi-Span): 50200050000510
  • HICL (First Databank): 001975
  • AHFS class code: 04:04.16.00
  • RxCUI (RxNorm): 995632
Why two NDCs? The FDA registers this code as 70677-1290-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70677-1290-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Antiemetic class.

Pharmacologic class Antiemetic
Drug family (ATC) Piperazine derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name FT MOTION SICKNESS 25 MG CHWTB Ingredient Meclizine Hcl
📖 What it is MedlinePlus · NLM

Meclizine is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. It is most effective if taken before symptoms appear.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Meclizine is mainly used to prevent and treat the nausea, vomiting, and dizziness that comes with motion sickness — whether you're on a boat, in a car, or on a plane. It's also use...
  • For the best chance of preventing motion sickness, take meclizine about one hour before you start traveling. After that first dose, you can take it once every 24 hours as needed fo...
  • Yes, drowsiness is the most common side effect — it's actually worth planning around. Avoid driving or operating heavy machinery until you know how it affects you. And definitely s...
  • This one requires a conversation with your doctor. Human studies haven't clearly linked meclizine to birth defects, but animal studies did show fetal harm at doses similar to what...
📖 Read our full Meclizine guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.033 $3.33 / 100 tablets
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2025 Mar 2026 Jun 2026 Sep 2026 $0.035 $0.033
▼ Down 4% over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70677-1290-01 You're viewing this Main listing 100 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC 2025-05-30 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Meclizine Hydrochloride 25 mg 00536-1299-01 Rugby 100 tablets $0.033 — Availability likely —
Meclizine HCl 25 mg 16571-0824-01 Rising 100 tablets $0.033 — Availability likely —
Motion Sickness Relief 25 mg 46122-0774-51 Amerisource 8 tablets $0.033 — Availability likely —
Motion-Time Chewable 25 mg/251 49483-0333-01 Time-Cap 100 tablets $0.033 — Availability likely —
Meclizine HCl 25 mg 68001-0529-00 BluePoint 100 tablets $0.033 — Availability likely —
Motion Sickness 25 mgthis 70677-1290-01 Strategic 100 tablets $0.033 — Availability likely —
Travel ease 25 mg 83324-0027-16 Chain 8 tablets $0.033 — Availability likely —
Motion Sickness Relief 25 mg 00363-4040-21 Walgreen 8 tablets — — FDA listed —
Meclizine Hydrochloride 25 mg 00363-5172-07 Walgreen 12 tablets — — FDA listed —
Motion Sickness Relief 25 mg 11822-4040-01 Rite 8 tablets — — FDA listed —
Meclizine 25 mg 16103-0387-08 Pharbest 100 tablets — — FDA listed —
Meclizine Hydrochloride 25 mg 16571-0663-01 Rising 100 tablets — — FDA listed —
Meclizine HCL 25 mg 17714-0115-01 Advance 100 tablets — — FDA listed —
Meclizine 25 mg 37835-0202-01 Bi-Mart 100 tablets — — FDA listed —
Meclizine 25 mg 43063-0804-01 PD-Rx 100 tablets — — FDA listed —
Meclizine Hydrochloride 25 mg 50090-5496-00 A-S 30 tablets — — FDA listed —
Meclizine Hydrochloride 25 mg 50090-5952-00 A-S 30 tablets — — FDA listed —
Motion Sickness Relief 25 mg 51013-0322-54 PuraCap 2 tablets — — FDA listed —
Motion Sickness Relief 25 mg 51316-0404-21 CVS 8 tablets — — FDA listed —
Motion Sickness 25 mg 51316-0441-21 CVS 8 tablets — — FDA listed —
Meclizine HCL 25 mg 54738-0025-01 Richmond 100 tablets — — FDA listed —
Dramamine 25 mg 63029-0906-12 Medtech 12 tablets — — FDA listed —
Dramamine 25 mg 63029-0913-12 Medtech 12 tablets — — FDA listed —
Dramamine 25 mg 63029-0914-12 Medtech 12 tablets — — FDA listed —
Bonine 25 mg 65197-0275-02 WellSpring 2 tablets — — FDA listed —
Bonine 25 mg 65197-0296-08 WellSpring 8 tablets — — FDA listed —
Bonine 25 mg 65197-0297-08 WellSpring 8 tablets — — FDA listed —
Meclizine Hydrochloride 25 mg 68071-2574-02 NuCare 20 tablets — — FDA listed —
Meclizine HCL 25 mg 68788-7982-01 Preferred 10 tablets — — FDA listed —
Meclizine HCl 25 mg 68788-8529-01 Preferred 10 tablets — — FDA listed —
Meclizine HCL 25 mg 69618-0028-01 Reliable 100 tablets — — FDA listed —
Motion Sickness Relief 25 mg 69842-0395-54 CVS 2 tablets — — FDA listed —
Meclizine HCL 25 mg 71205-0606-30 Proficient 30 tablets — — FDA listed —
Meclizine 25 mg 71335-1215-00 Bryant 120 tablets — — FDA listed —
Meclizine HCL 25 mg 71335-1607-00 Bryant 120 tablets — — FDA listed —
Meclizine Hydrochloride 25 mg 71335-2177-00 Bryant 120 tablets — — FDA listed —
Meclizine HCl 25 mg 71335-9751-00 Bryant 120 tablets — — FDA listed —
Meclizine HCL 25 mg 71610-0528-30 Aphena 30 tablets — — FDA listed —
Meclizine Hydrochloride 25 mg 71610-0836-30 Aphena 30 tablets — — FDA listed —
Meclizine Hydrochloride 25 mg 72789-0250-12 PD-Rx 12 tablets — — FDA listed —
Meclizine 25 mg 80513-0421-02 Advanced 200 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
May 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color pink
ShapeRound
Imprint44;404
Size9 mm
ScoringNot scored
FlavorRaspberry
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII IY9XDZ35W2
    Dextrose is a simple sugar derived from corn or other sources. It serves as a filler and sweetener in medicines to add bulk, improve taste, and help stabilize the medication's form.
  • UNII 6T47AS764T
    Red 40 Lake is a synthetic colorant made by combining Red 40 dye with aluminum hydroxide. It's used to give tablets, capsules, and other medicines a red or pink color for identification and appearance.
  • UNII EWQ57Q8I5X
    Lactose monohydrate is a natural sugar derived from milk. It serves as a filler and binder in tablets and capsules, helping create the proper size, texture, and consistency of the medicine.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII SB8ZUX40TY
    Saccharin sodium is an artificial sweetener made from saccharin salt. It's added to medicines to improve taste, especially in liquid formulations for children or bitter drugs.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII O8232NY3SJ
    A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.

8 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescolloidal silicon dioxide, dextrose, FD&C red #40 aluminum lake, flavor, lactose monohydrate, magnesium stearate, pregelatinized starch, propylene glycol, saccharin sodium, silicon dioxide

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerStrategic Sourcing Services LLC
FDA applicationM009 (OTC MONOGRAPH DRUG)
Labeler code70677
First marketedMay 2025
Product typeHuman Otc Drug
Portfolio316 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 Ask a Doctor or Pharmacist Before Use If 📄 When Using This Product 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 14 words ▾

Uses for prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness

⏱️ Dosage and Administration 49 words ▾

Directions do not take more than directed dosage should be taken one hour before travel starts chew or crush tablets completely before swallowing; do not swallow tablets whole adults and children 12 years and over: take 1 to 2 chewable tablets once daily or as directed by a doctor

⚠️ Warnings 116 words ▾

Warnings Do not use for children under 12 years of age unless directed by a doctor. Ask a doctor before use if you have glaucoma difficulty in urination due to enlargement of the prostate gland a breathing problem such as emphysema or chronic bronchitis Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers. When using this product drowsiness may occur alcohol, sedatives, and tranquilizers may increase drowsiness avoid alcoholic beverages use caution when driving a motor vehicle or operating machinery If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 41 words ▾

Other information TAMPER EVIDENT: DO NOT USE IF OUTER PACKAGE IS OPENED OR BLISTER IS TORN OR BROKEN store at 25ºC (77ºF); excursions permitted between 15º-30ºC (59º-86ºF) protect from heat and humidity see end flap for expiration date and lot number

🧪 Active Ingredient 10 words ▾

Active ingredient (in each chewable tablet) Meclizine HCl 25 mg

🧪 Inactive Ingredients 24 words ▾

Inactive ingredients colloidal silicon dioxide, dextrose, FD&C red #40 aluminum lake, flavor, lactose monohydrate, magnesium stearate, pregelatinized starch, propylene glycol, saccharin sodium, silicon dioxide

🎯 Purpose 2 words ▾

Purpose Antiemetic

📄 Do Not Use 15 words ▾

Do not use for children under 12 years of age unless directed by a doctor.

📄 Ask a Doctor Before Use If 28 words ▾

Ask a doctor before use if you have glaucoma difficulty in urination due to enlargement of the prostate gland a breathing problem such as emphysema or chronic bronchitis

📄 Ask a Doctor or Pharmacist Before Use If 14 words ▾

Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.

📄 When Using This Product 27 words ▾

When using this product drowsiness may occur alcohol, sedatives, and tranquilizers may increase drowsiness avoid alcoholic beverages use caution when driving a motor vehicle or operating machinery

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 4 words ▾

Questions or comments? 1-800-426-9391

📄 Package Label / Principal Display Panel 122 words ▾

Principal Display Panel NDC 70677-1290-1 *COMPARE TO THE ACTIVE INGREDIENT IN BONINE ® CHEWABLE TABLETS Foster & Thrive Motion Sickness Meclizine HCl 25 mg Chewable Tablets ANTIEMETIC Helps Prevent Nausea, Vomiting and Dizziness due to Motion Sickness for up to 24 Hours Ages 12 Years and Over Chew or crush tablets completely before swallowing. 100 CHEWABLE TABLETS RASPBERRY FLAVOR TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING *This product is not manufactured or distributed by WellSpring Pharmaceutical Corporation, owner of the registered trademark Bonine ® Chewable Tablets.

50844 ORG082340412 Rev. 02/25 ©2023 McKesson Corporation Distributed by: McKesson Corp., via SSSL, Memphis, TN 38141 Money Back Guarantee www.fosterandthrive.com Foster and thrive 44-404A Foster and thrive 44-404A

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Meclizine HCl (matched by generic name) — the program that covers self-administered drugs. 8 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Meclizine HCl. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$6.73M
Claims incl. refills
748.9K
Beneficiaries
532.6K
Spend / beneficiary
$12.64
Spend / claim
$8.99
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
← 70677-1289-01 · Strategic 70677-1291-01 · Strategic →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.